Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-volume versus low-volume suprascapular nerve block for rotator cuff tear
ACTRN12621001536853Phase 4Not yet recruiting
- Sponsor
- Colchester Hospital University NHS Foundation Trust
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine and betamethasone in rotator cuff tear (2 arms), sponsored by Colchester Hospital University NHS Foundation Trust. Primary endpoint: Constant-Murley Score at 12 months. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
bupivacainebetamethasone
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on ACTRN12621001536853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001536853.